[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Generate Biomedicines Inc (GENB)

Generate Biomedicines Inc (GENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts

Newly Constructed Phase 2 now 100% Leased

GENB : 14.39 (+5.96%)
Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

SOMERVILLE, Mass. , May 28, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) today announced that it intends to participate in the Goldman Sachs Global Healthcare Conference on Monday,...

GENB : 14.39 (+5.96%)
This AI Biotech Stock Landed a $10.4 Million Nvidia Investment

Nvidia’s backing highlights growing confidence in AI-powered biotech stocks.

NVDA : 207.29 (+1.97%)
GENB : 14.39 (+5.96%)
NVS : 153.87 (+2.88%)
AMGN : 366.24 (+0.57%)
A Deep Dive Into NVIDIA’s Latest Portfolio Moves

NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example.

NVDA : 207.29 (+1.97%)
CRWV : 79.58 (+8.92%)
GENB : 14.39 (+5.96%)
INTC : 105.45 (+8.64%)
SNPS : 389.07 (+2.80%)
COHR : 317.22 (+11.15%)
NBIS : 216.92 (+18.78%)
RXRX : 3.07 (+6.23%)
NOK : 10.63 (+5.46%)
LITE : 837.56 (+9.41%)
MRVL : 207.96 (+6.68%)
Generate Biomedicines: Q1 Earnings Snapshot

Generate Biomedicines: Q1 Earnings Snapshot

GENB : 14.39 (+5.96%)
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update

SOMERVILLE, Mass. , May 7, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (NASDAQ: GENB) ("Generate") today reported financial results for the first quarter ended March 31, 2026, and highlighted...

GENB : 14.39 (+5.96%)
Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

SOMERVILLE, Mass. , Feb. 26, 2026 /PRNewswire/ -- Generate Biomedicines, Inc. (Nasdaq: GENB) ("Generate"), a clinical-stage generative biology company pioneering the AI revolution in biotechnology...

GENB : 14.39 (+5.96%)

Barchart Exclusives

Barclays Just Upgraded CarMax Stock. Here's Why.
CarMax stock extends gains as Barclays lifts rating to Equal Weight. But caution is warranted in playing KMX shares at current levels. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.